Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

13.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

From Idea to Data: An Agentic Architecture for the Clinical Trial Life Cycle.

Studies in health technology and informatics·2026
Same author

LLM-Assisted Clinical Data Harmonization: Combining Automated ETL Generation with Semantic Vocabulary Mapping for OMOP CDM.

Studies in health technology and informatics·2026
Same author

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial.

Nature medicine·2026
Same author

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Liver-directed lentiviral gene therapy confers durable hepatic and systemic amelioration of methylmalonic acidemia in mice.

Journal of hepatology·2026

Related Experiment Video

Updated: Feb 24, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.5K

Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.

Simone J Scholz1, Raffaele Fronza1,2, Cynthia C Bartholomä1

  • 11 Department of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases , Heidelberg, Germany .

Human Gene Therapy
|August 22, 2017
PubMed
Summary
This summary is machine-generated.

This study reveals that lentiviral vector integration site selection depends on promoter presence, not its type. Self-inactivating lentiviral vectors reduce unwanted fusion transcripts, aiding gene therapy vector optimization.

Keywords:
fusion transcriptsgenotoxicityintegration sitelentiviral vectors

More Related Videos

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.9K
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

16.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.5K
Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.9K
A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
10:42

A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells

Published on: December 12, 2017

16.3K

Area of Science:

  • * Molecular biology
  • * Gene therapy
  • * Virology

Background:

  • * Lentiviral vectors are promising for inherited disease genetic correction.
  • * Understanding lentiviral vector integration and modification mechanisms is crucial for effective gene therapy.
  • * Previous research has not fully elucidated lentiviral vector behavior.

Purpose of the Study:

  • * To investigate lentiviral vector target site selection and gene expression perturbation.
  • * To analyze the impact of promoter type and self-inactivating (SIN) long terminal repeat (LTR) structures on vector integration.
  • * To assess the formation of viral-cellular fusion transcripts.

Main Methods:

  • * Utilized an optimized nonrestrictive linear amplification-mediated polymerase chain reaction (nrLAM-PCR) protocol.
  • * Transduced mouse lin- hematopoietic progenitors in vitro with various lentiviral vectors.
  • * Analyzed integration site profiles and viral-cellular fusion transcript formation.

Main Results:

  • * Integration site selection primarily depended on the presence of a promoter, irrespective of its specific type.
  • * Self-inactivating (SIN) lentiviral vectors showed reduced viral-cellular fusion transcript formation.
  • * Internal promoter strength in SIN lentiviral vectors influenced in vitro selection and chimeric transcript abundance, with moderate promoters decreasing them.

Conclusions:

  • * Lentiviral vector integration is directed by promoter presence.
  • * SIN lentiviral vectors offer improved safety by reducing fusion transcripts.
  • * Findings aid in optimizing lentiviral vectors for enhanced gene therapy applications.